video

FUTUREPROOF Episode Three, Part One

Matt Gooderick looks at the potential for the use of artificial intelligence in the health sector, including initiatives by IBM Watson, BenevolentAI and Babylon.

BenevolentAI on BBC Business Live

Listen to Kenneth Mulvany, CEO BenevolentAI discussing AI in Medicine at BBC Business Live

Jackie Hunter speaking at The House of Lords

Professor Jackie Hunter, CEO, BenevolentBio, gave evidence at The House of Lords Science and Technology Select Committee

Ken Mulvany talks to CNBC at Goldman Sachs’ Disruptive Technology Symposium

Listen to our founder Ken Mulvany discussing BenevolentAI's work on artificial intelligence applied to drug discovery.

Jérôme Pesenti, CEO BenevolentTech at Project Juno AI Showcase

Jérôme Pesenti introduces BenevolentAI's work on applying artificial intelligence to improve scientific discoveries

Jackie Hunter @ TechCrunch Disrupt London 2016

Ken Mulvany discusses AI, machine learning and the need to build morality into the technology

BenevolentAI – Accelerating Scientific Discovery With AI

BenevolentAI team explains why the use of DGX-1 will help them in their daily work

NVIDIA DGX-1 - Unboxing at BenevolentAI

BenevolentAI London Office

by the team at BenevolentAI